Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

NCT06555133 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Carcinoma Metastatic in the Liver

Interventions

COMBINATION_PRODUCT: yttrium-90 radioembolization

Sponsor

Brown University

Collaborators

[object Object]
[object Object]